LUND, Sweden, 27 April, 2018 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) ("NeuroVive") today on 27 April 2018 held its Annual General Meeting (AGM). A summary of the resolutions follows. All resolutions were passed with the required majority....
from PR Newswire: //https://ift.tt/2r4EsG3
No comments:
Post a Comment